By Buy This GLP Editorial Team · Editorial profile: Neil Sanders
Signos review
Medication and biosensor bundle
Signos+ combines eligible prescription access with app features and a limited number of biosensors.
A comparable monthly medication price is not available. See the plan details below for published fees, medication costs and payment terms.
The bottom line
Signos+ advertises plans from $199 per month for eligible members. Its help center describes 12- and 24-week plans with different numbers of Stelo biosensors, and the public price does not establish a fixed bill for each medicine.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
What the figure does not cover
Fees, terms and cancellation at Signos
- Cancellation
- Signos says plans renew automatically and that patients can cancel a future renewal without ending the current paid term.
Pricing transparency
How Signos publishes its prices
Compare the total cost of the bundle with a medication-only option, using the medication supply and sensor count for the same period. The $199 advertised equivalent does not establish the full charge for every prescription or term.
At a glance
- Category
- GLP-1 sellers by price
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Prescription
- Required
The seller
What Signos is
Signos+ is a treatment bundle that pairs eligible GLP-1 access with a glucose monitoring app and biosensors.
How it works
The clinician determines whether medication is appropriate. The help center lists two 15-day sensors on a 12-week plan and four on a 24-week plan.
Branded or compounded
Compounded medications lack FDA approval and premarket review for safety, effectiveness or quality.
Where the money holds, and where it moves
Predictable
- Describes the structure of its treatment offer
Moves, or is not stated
- Confirm qualification and billing for the specific plan
Who this is worth it for
People evaluating the sensor and medication offer together.
Who should price elsewhere
People who want medication-only pricing or continuous sensor supply throughout every plan week.
The molecules
What Signos prescribes, and the evidence for it
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Oral Semaglutide vs Injection: Wegovy Doses and Trial Results
In the US, Wegovy tablet maintenance is 25 mg daily. The usual recommended injection dose is 2.4 mg weekly for adults managing weight.
- Is Tirzepatide Worth the Extra Cost Over Semaglutide?
Average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide in a head-to-head trial. A separate observational study found an uncertain difference in cardiovascular outcomes.
Priced against
Sellers to price beside Signos
RxION Health
People who can confirm the medication, charge and refill interval in writing.
See RxION Health →
RX BellaPeople comparing publicly advertised starting prices.
See RX Bella →Science & Co
Buyers who obtain the full commitment and renewal terms in writing
See Science & Co →
More GLP-1 sellers by price priced end to end: Lavender Sky HealthLaylaLean MedsLean RxLeanDoseLemonaid Health
Sponsored alternative
SkinnyRx
Buyers choosing tirzepatide who want its standing rate before an intake
Check SkinnyRx availability →Provider information
Plans and terms behind the assessment
Checked . Confirm current terms before paying.
Or go back to the price desk and compare Signos against every seller on it.